Euchloe Bio Overview

  • Year Founded
  • 2016

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

  • Financing Rounds
  • 1

Euchloe Bio General Information

Description

Developer of novel antibody-based immunotherapeutic intended to treat cancer. The company's novel antibody-based immunotherapeutic include fully-human antibodies, checkpoint receptor antagonists and immune system agonists using proprietary antibody engineering technology.

Contact Information

Website
www.euchloe.com
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 8 Temasek Boulevard
  • Suite 24-02
  • Singapore, 038988
  • Singapore
Primary Industry
Biotechnology
Vertical(s)
Corporate Office
  • 8 Temasek Boulevard
  • Suite 24-02
  • Singapore, 038988
  • Singapore

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Euchloe Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Euchloe Bio‘s full profile, request access.

Request a free trial

Euchloe Bio Patents

Euchloe Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2020094834-A1 Il2rbeta/common gamma chain antibodies Inactive 09-Nov-2018
WO-2020094836-A1 Il2rbeta/common gamma chain antibodies Inactive 09-Nov-2018
US-20240052046-A1 Il2rbeta/common gamma chain antibodies Inactive 04-Apr-2018
EP-3707162-A1 Il2rbeta/common gamma chain antibodies Pending 10-Nov-2017
WO-2019092181-A1 Il2rbeta/common gamma chain antibodies Inactive 10-Nov-2017 C07K16/2866
To view Euchloe Bio’s complete patent history, request access »

Euchloe Bio FAQs

  • When was Euchloe Bio founded?

    Euchloe Bio was founded in 2016.

  • Where is Euchloe Bio headquartered?

    Euchloe Bio is headquartered in Singapore, Singapore.

  • What industry is Euchloe Bio in?

    Euchloe Bio’s primary industry is Biotechnology.

  • Is Euchloe Bio a private or public company?

    Euchloe Bio is a Private company.

  • What is Euchloe Bio’s current revenue?

    The current revenue for Euchloe Bio is .

  • When was Euchloe Bio acquired?

    Euchloe Bio was acquired on 23-Mar-2017.

  • Who acquired Euchloe Bio?

    Euchloe Bio was acquired by Tessa Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process